He Ran 500 Miles on Psychedelics. The Real Lesson Wasn’t About Energy.
Ultrarunner Dante Liberato ran roughly 500 miles from Colorado to Moab in about 11 days — while microdosing psilocybin and LSD the entire way — with a film crew documenting every mile. The result, a documentary titled “Dante,” has been making the rounds precisely because it refuses to be the story people expected.
The arc: “rocket fuel,” then a wall
Early on, Liberato described a dose as feeling like “rocket fuel” — sharpened focus, fatigue melting away deep into a 100-mile push. It’s the kind of moment that launches a thousand microdosing-for-performance takes. But around mile 241, it flipped. The psychedelics stopped helping and started making him more tired.
His own read on it is the interesting part: he concluded the compounds weren’t generating energy — they were redistributing it, pulling on metabolic resources his depleted body simply didn’t have left. The “boost” wasn’t free. Somewhere in the back half of an 11-day effort, the bill came due.
The turn wasn’t chemical
The shift he credits most didn’t come from a dose at all. Liberato says the real change came when he stopped dosing and started crying — releasing suppressed emotion he believes had been quietly driving cortisol and inflammation the whole time. His summary line is one we would frame on the wall here: “None of these medicines will give you the answers to your problems.”
What the science does — and doesn’t — back up
There is a real mechanism underneath the hype. Psilocybin may open a neuroplastic window — research points to increased BDNF (a protein tied to forming new neural connections) and a quieter default mode network, the brain’s self-referential “autopilot.” That window is a genuine and active area of study.
But two honest caveats matter:
- Microdosing for performance is not supported by controlled evidence. When researchers put microdosing into double-blind, placebo-controlled trials, the energy-and-focus gains largely did not beat placebo — they track with expectation, not pharmacology. Liberato’s own “rocket fuel → wall” experience is a vivid, single-person illustration of why anecdote is not evidence.
- A neuroplastic window is not a fix. As Liberato puts it, the compound may open the window, but what fills it is up to you. The science echoes the humility: the molecule is, at most, a catalyst for work — not a substitute for it.
Why this story lands
Strip away the psychedelics and you are left with a surprisingly old-fashioned message: no compound does the actual emotional work for you. That is what makes “Dante” worth watching — not as a how-to, but as a raw, self-aware n-of-1 that arrives at the opposite of a shortcut.
What this does not mean
- This is a documentary story, not a protocol — and emphatically not medical, dosing, or performance advice.
- Psilocybin and LSD are controlled substances in most jurisdictions. Running 500 miles on them is an extreme stunt with real medical risk; do not attempt it.
- “May suggest” and “was associated with” are deliberate — neuroplasticity research is early, and none of this is a promise of results.
Sources
- ¶Dante Liberato ran 500 miles while microdosing — Outside
- ¶A Manitou Springs athlete ran 500 miles to Moab — Colorado Sun
- ¶“Dante” documentary follows Colorado man’s 500-mile run — Axios
- ¶Microdosing psilocybin — double-blind, placebo-controlled study (Nature)
Educational Disclaimer
This article is for informational and educational purposes only. It is not medical advice, mental health advice, diagnosis, treatment guidance, or a recommendation to use any substance, supplement, therapy, or protocol.
We review publicly available research and explain what the evidence may suggest. Some studies may be early-stage, observational, animal-based, lab-based, theoretical, or incomplete. Always consult a qualified professional before making health-related decisions.
Researched and drafted by Spore, ShroomWire’s AI research assistant, and reviewed by the ShroomWire editorial team before publishing.
